Literature DB >> 21395506

Functional roles of osteoactivin in normal and disease processes.

Maneet Singh1, Fabiola Del Carpio-Cano, Joyce Y Belcher, Kevin Crawford, Nagat Frara, Thomas A Owen, Steven N Popoff, Fayez F Safadi.   

Abstract

Osteoactivin (OA) protein was discovered in bone cells a decade ago. Recent literature suggests that osteoactivin is crucial for the differentiation and functioning of different cell types, including bone-forming osteoblasts and bone-resorbing osteoclast cells. Here, we review the literature to date on various regulatory functions of osteoactivin, as well as its discovery, structure, expression, and function in different tissues and cells. The transcriptional regulation of osteoactivin and its mechanism of action in normal and diseased conditions with special emphasis on bone are also covered in this review. In addition, we touch on the therapeutic potential of osteoactivin in cancer and bone diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21395506     DOI: 10.1615/critreveukargeneexpr.v20.i4.50

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN: 1045-4403            Impact factor:   1.807


  16 in total

1.  Mutation in Osteoactivin Promotes Receptor Activator of NFκB Ligand (RANKL)-mediated Osteoclast Differentiation and Survival but Inhibits Osteoclast Function.

Authors:  Samir M Abdelmagid; Gregory R Sondag; Fouad M Moussa; Joyce Y Belcher; Bing Yu; Hilary Stinnett; Kimberly Novak; Thomas Mbimba; Matthew Khol; Kurt D Hankenson; Christopher Malcuit; Fayez F Safadi
Journal:  J Biol Chem       Date:  2015-04-02       Impact factor: 5.157

2.  Molecular profiling of failed endochondral ossification in mucopolysaccharidosis VII.

Authors:  Sun H Peck; John W Tobias; Eileen M Shore; Neil R Malhotra; Mark E Haskins; Margret L Casal; Lachlan J Smith
Journal:  Bone       Date:  2019-08-20       Impact factor: 4.398

3.  Transgenic Expression of Osteoactivin/gpnmb Enhances Bone Formation In Vivo and Osteoprogenitor Differentiation Ex Vivo.

Authors:  Nagat Frara; Samir M Abdelmagid; Gregory R Sondag; Fouad M Moussa; Vanessa R Yingling; Thomas A Owen; Steven N Popoff; Mary F Barbe; Fayez F Safadi
Journal:  J Cell Physiol       Date:  2016-01       Impact factor: 6.384

Review 4.  Glycoprotein Non-Metastatic Melanoma Protein B (GPNMB) and Cancer: A Novel Potential Therapeutic Target.

Authors:  Manisha Taya; Stephen R Hammes
Journal:  Steroids       Date:  2017-10-31       Impact factor: 2.668

5.  Comprehensive genomic analysis contrasting primary colorectal cancer and matched liver metastases.

Authors:  Akio Shiomi; Masatoshi Kusuhara; Takashi Sugino; Teiichi Sugiura; Keiichi Ohshima; Takeshi Nagashima; Kenichi Urakami; Masakuni Serizawa; Hideyuki Saya; Ken Yamaguchi
Journal:  Oncol Lett       Date:  2021-04-12       Impact factor: 2.967

6.  Mutation in osteoactivin decreases bone formation in vivo and osteoblast differentiation in vitro.

Authors:  Samir M Abdelmagid; Joyce Y Belcher; Fouad M Moussa; Suzanne L Lababidi; Gregory R Sondag; Kimberly M Novak; Afif S Sanyurah; Nagat A Frara; Roshanak Razmpour; Fabiola E Del Carpio-Cano; Fayez F Safadi
Journal:  Am J Pathol       Date:  2014-01-23       Impact factor: 4.307

7.  Comparative transcriptome analysis of muscular dystrophy models Large(myd), Dmd(mdx)/Large(myd) and Dmd(mdx): what makes them different?

Authors:  Camila F Almeida; Poliana Cm Martins; Mariz Vainzof
Journal:  Eur J Hum Genet       Date:  2016-03-02       Impact factor: 4.246

8.  Quantitative trait locus mapping identifies the Gpnmb gene as a modifier of mouse macrophage lysosome function.

Authors:  Peggy Robinet; Brian Ritchey; Shuhui Wang Lorkowski; Alexander M Alzayed; Sophia DeGeorgia; Eve Schodowski; C Alicia Traughber; Jonathan D Smith
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

9.  Integration analysis of microRNA and mRNA expression profiles in human peripheral blood lymphocytes cultured in modeled microgravity.

Authors:  C Girardi; C De Pittà; S Casara; E Calura; C Romualdi; L Celotti; M Mognato
Journal:  Biomed Res Int       Date:  2014-06-23       Impact factor: 3.411

10.  Glycoprotein non-metastatic b (GPNMB): A metastatic mediator and emerging therapeutic target in cancer.

Authors:  Gordana Maric; April An Rose; Matthew G Annis; Peter M Siegel
Journal:  Onco Targets Ther       Date:  2013-07-09       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.